Vitrolife AB VITR-SE:Stockholmsborsen

RT Quote | Exchange | SEK
Last | 04/24/24 CEST
162.80UNCH (UNCH)
52 week range
159.90 - 205.40
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close162.80
  • 52 Week High205.40
  • 52 Week High Date03/14/24
  • 52 Week Low159.90
  • 52 Week Low Date04/18/24

Key Stats

  • Market Cap2,027.35M
  • Shares Out135.39M
  • 10 Day Average Volume142,381.3
  • Dividend1.00
  • Dividend Yield0.61%
  • Beta2.55
  • YTD % Change-16.38

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close162.80
  • 52 Week High205.40
  • 52 Week High Date03/14/24
  • 52 Week Low159.90
  • 52 Week Low Date04/18/24
  • Market Cap2,027.35M
  • Shares Out135.39M
  • 10 Day Average Volume142,381.3
  • Dividend1.00
  • Dividend Yield0.61%
  • Beta2.55
  • YTD % Change-16.38

RATIOS/PROFITABILITY

  • EPS (TTM)-28.34
  • P/E (TTM)-5.74
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date04/28/2023
  • Div Amount0.85
  • Split Date-
  • Split Factor-

Latest On Vitrolife AB

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte...
Jon Sigurdsson
Chairman of the Board
Bronwyn Brophy
President, Chief Executive Officer
Patrik Tolf
Chief Financial Officer
Guillermo Ferrando
Vice President - Strategy and Corporate Development
Address
Gustaf Werners gata 2, Vastra Frolunda
Goeteborg
421 32
Sweden